SOD1 and mild neurocognitive disorder: Moreover, since pathogenic loss of function has been discussed as a possible cause of MND in children with homozygous mutations,13,14 it would be interesting to clarify whether positive effects of tofersen can be reproduced in this subgroup, or whether tofersen leads to worsening of symptoms by reducing SOD1 protein levels in these patients.